<?xml version="1.0" encoding="UTF-8"?>	<item><venue><address_2>Suite Number: 4000, North Entrance</address_2><address_1>1000 Winter Street, Bay Colony Corporate Center</address_1><state>MA</state><zip>02451</zip><lat>42.394714</lat><repinned>False</repinned><name>Emerging Enterprise Center at Foley Hoag</name><city>Waltham</city><id>597058</id><country>us</country><lon>-71.251785</lon></venue><fee><label>Price</label><accepts>cash</accepts><currency>USD</currency><description>per person</description><amount>25.0</amount><required>0</required></fee><status>past</status><description>&lt;p&gt;&lt;span style="font-size : x-small"&gt;&lt;span&gt;&lt;strong&gt;&lt;span style="color : #003399"&gt;Biomedicine: Riding and Surviving the Biotech Funding Roller-Coaster&lt;/span&gt; &lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;a href="http://www.entretechforum.org"&gt;www.entretechforum.org&lt;/a&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;Biotech venture capital interest has been running hot and cold in the last few years, much to the discomfort of entrepreneurs and early stage investors in the sector trying to manage the hard slog through new venture rounds.&lt;/p&gt;
&lt;p&gt;After proceeding from strength to strength through 2007, national biotech funding nose-dived in 2008, and is only now bouncing back from 2009 lows. 2010 has seen modest and wobbly increases in interest in the sector, with Thompson Financial reporting $3.7 billion going into 460 deals. Even so, 4Q10 Biotechnology investing declined 24% in dollars and fell 15% in the number of deals from the third quarter with $685 million going into 94 rounds. Given this volatility, what&amp;rsquo;s a biotech CEO or early stage investor to do, given the huge capital requirements of the sector to deliver a product?&lt;/p&gt;
&lt;p&gt;The March 15th EntreTech Forum panel brings together local experts on the subject who have lived through the ups and downs of the recent funding environment. The panel will be focused on providing the audience with their experiences and perspectives on how biotech leaders can thrive (or at least survive!) in the present and near future.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Panelists: &lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;&lt;a&gt;&lt;span style="color : #194584"&gt;Dr. William Li&lt;/span&gt;&lt;/a&gt;, M.D. &amp;ndash; President and Medical Director &amp;ndash; The Angiogenesis Foundation &lt;br /&gt;&lt;a&gt;&lt;span style="color : #194584"&gt;Philip Thomas&lt;/span&gt;&lt;/a&gt; &amp;ndash; CEO &amp;ndash; LaserHeart and Owner &amp;ndash; Boston Business Group &lt;br /&gt;&lt;a&gt;&lt;span style="color : #194584"&gt;Eric Evans&lt;/span&gt;&lt;/a&gt; &amp;ndash; Angel Investor with Launchpad Venture Group and Mass Medical Angels &amp;ndash; Former CEO Targeted Cell Therapies&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt; &lt;br /&gt;&lt;strong&gt;Meeting Organizers:&lt;/strong&gt; &lt;br /&gt;&lt;strong&gt;&lt;a&gt;&lt;span style="color : #194584"&gt;Andrew Fairbairn&lt;/span&gt;&lt;/a&gt;&lt;/strong&gt; &amp;ndash; Managing Principal &amp;ndash; Fairbairn Ventures &lt;br /&gt;&lt;strong&gt;&lt;a&gt;&lt;span style="color : #194584"&gt;Larry Grumer&lt;/span&gt;&lt;/a&gt;&lt;/strong&gt; &amp;ndash; Managing Director &amp;ndash; TAA Corp.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;&lt;span style="color : #ffffff"&gt;&lt;span&gt;Meeting Location:&lt;/span&gt; &lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span&gt;Emerging Enterprise Center at  &lt;br /&gt;Foley Hoag the Bay Colony Corporate Center &lt;br /&gt;1000 Winter Street, Suite 4000 (North Entrance) &lt;br /&gt;Waltham, MA&amp;nbsp;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Meeting Time:&lt;/strong&gt; 6:30 - 9:30 pm&lt;/p&gt;
&lt;p&gt;&lt;span&gt;&lt;strong&gt;Meeting Cost: &lt;br /&gt;&lt;/strong&gt;$25 public, $10 students &lt;br /&gt;and active military; &lt;/span&gt;&lt;a&gt;&lt;strong&gt;&lt;span style="color : #194584"&gt;Promotional Registrations&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;</description><event_hosts><event_hosts_item><member_name>Larry Grumer</member_name><member_id>12792562</member_id></event_hosts_item></event_hosts><maybe_rsvp_count>0</maybe_rsvp_count><waitlist_count>0</waitlist_count><updated>1300232690000</updated><rating><average>0.0</average><count>0</count></rating><group><who>Technology Entrepreneurs</who><join_mode>open</join_mode><urlname>EntreTechForum</urlname><id>1133540</id><group_lat>42.3400001526</group_lat><group_lon>-71.0899963379</group_lon><name>The EntreTech Forum</name></group><yes_rsvp_count>4</yes_rsvp_count><created>1282750881000</created><visibility>public</visibility><name>Biomedicine: Riding and Surviving the Biotech Funding Roller-Coaster</name><id>kdwhpypfbtb</id><headcount>0</headcount><utc_offset>-14400000</utc_offset><time>1300228200000</time><event_url>http://www.meetup.com/EntreTechForum/events/16674181/</event_url></item>